Renata Medical Closes $25M Series D Financing Led by Global Healthcare Investment Firm ARCHIMED to Accelerate Commercialization and Development of Pediatric Cardiovascular Technologies
NEWPORT BEACH, Calif., Aug. 19, 2026 /PRNewswire/ -- Renata Medical, a privately held medical technology company dedicated to transforming care for children with congenital heart disease (CHD), today announced the close of a $25 million Series D financing round. The round was led by...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.